TY - JOUR
T1 - Symptom dimensions of anxiety in Parkinson's disease
T2 - Replication study in a neuropsychiatric patient population
AU - Rutten, Sonja
AU - van Wegen, Erwin E. H.
AU - Ghielen, Ires
AU - Schoon, Bridget
AU - van den Heuvel, Odile A.
N1 - Funding Information: This research was funded by the Dutch Parkinson patient association (grant number 2013R16 ) and the Dutch Brain Foundation (grant number SBB2017-04 ). The funding agency was not involved in the content of the research or the preparation of this manuscript. The authors would like to thank prof. dr. Henk W. Berendse, neurologist at Amsterdam UMC, for his contribution to this manuscript, by critical comments on the draft text. Publisher Copyright: © 2021 The Author(s)
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Introduction: Anxiety disorders occur in approximately one third of people with Parkinson's disease (PD), and have a major impact on patient and caregiver wellbeing. In order to better understand and diagnose anxiety in PD patients, we investigated the generalizability of the results of a previous factor analysis on anxiety symptoms to a sample of PD patients with neuropsychiatric symptoms. Methods: In this cross-sectional study, anxiety symptoms were measured with the Beck Anxiety Inventory (BAI) in 123 PD patients who were referred for neuropsychiatric diagnostics and treatment. Subscales of anxiety were analyzed through principal component analysis of BAI items. The associations between BAI subscales and symptoms of motor and cognitive function and depression were assessed through regression analyses. Results: Similar to the previous factor analysis, we found one psychological (affective) and four somatic subscales of anxiety in the BAI. The affective subscale was the principal component explaining 35.9% of the variance. The scores on the total BAI and the affective subscale were significantly associated with depressive symptoms. In a post-hoc analysis, the affective subscale had equal power as compared to the total BAI in predicting whether or not participants were diagnosed with an anxiety disorder after psychiatric evaluation. Conclusion: In this study, we replicated our previous findings of one affective and multiple somatic subscales of the BAI. The 7-item affective subscale of the BAI shows potential as a screening tool for non-episodic anxiety in PD. However, in clinical practice, we recommend evaluating anxiety symptoms in the context of other PD symptoms, including motor, autonomic, and other (neuro)psychiatric symptoms.
AB - Introduction: Anxiety disorders occur in approximately one third of people with Parkinson's disease (PD), and have a major impact on patient and caregiver wellbeing. In order to better understand and diagnose anxiety in PD patients, we investigated the generalizability of the results of a previous factor analysis on anxiety symptoms to a sample of PD patients with neuropsychiatric symptoms. Methods: In this cross-sectional study, anxiety symptoms were measured with the Beck Anxiety Inventory (BAI) in 123 PD patients who were referred for neuropsychiatric diagnostics and treatment. Subscales of anxiety were analyzed through principal component analysis of BAI items. The associations between BAI subscales and symptoms of motor and cognitive function and depression were assessed through regression analyses. Results: Similar to the previous factor analysis, we found one psychological (affective) and four somatic subscales of anxiety in the BAI. The affective subscale was the principal component explaining 35.9% of the variance. The scores on the total BAI and the affective subscale were significantly associated with depressive symptoms. In a post-hoc analysis, the affective subscale had equal power as compared to the total BAI in predicting whether or not participants were diagnosed with an anxiety disorder after psychiatric evaluation. Conclusion: In this study, we replicated our previous findings of one affective and multiple somatic subscales of the BAI. The 7-item affective subscale of the BAI shows potential as a screening tool for non-episodic anxiety in PD. However, in clinical practice, we recommend evaluating anxiety symptoms in the context of other PD symptoms, including motor, autonomic, and other (neuro)psychiatric symptoms.
KW - Anxiety
KW - Factor analysis
KW - Neuropsychiatry
KW - Non-motor symptoms
KW - Parkinson's disease
KW - Replication
KW - Symptom interaction
UR - http://www.scopus.com/inward/record.url?scp=85119060897&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.prdoa.2021.100117
DO - https://doi.org/10.1016/j.prdoa.2021.100117
M3 - Article
C2 - 34825163
SN - 2590-1125
VL - 5
JO - Clinical Parkinsonism and Related Disorders
JF - Clinical Parkinsonism and Related Disorders
M1 - 100117
ER -